HLA-DR Antibody [LN3] (FITC)
Product Specifications
Background
The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR), a MHC class II heterodimeric surface glycoprotein. HLA-DR is expressed on the antigen presenting surfaces of monocytes, macrophages, dendritic cells, activated T cells, and B cells. It is integral to peptide presentation to CD4+ T cells.
NCBI Gene ID
3122
Swiss Prot
P01903
Host
Mouse
Reactivity
Human
Clonality
Monoclonal
Clone
LN3
Conjugation
FITC
Type
Primary Antibodies
Field of Research
Immunology
Purification
The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
Concentration
Batch dependent
Buffer
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
The product should be stored undiluted at 4˚ C and should be protected from prolonged exposure to light. Do not freeze.
Fragment
Mouse IgG2b, kappa
Specificity
The LN3 monoclonal antibody specifically reacts with the human leukocyte antigen-DR (HLA-DR), a MHC class II heterodimeric surface glycoprotein.
Symbol
HLA-DRA
NCBI Official Name
Major histocompatibility complex, class II, DR alpha
NCBI Organism
Homo sapiens
Other Product Names
MLRW, HLA-DRA1, HLA-DRA
Tested Applications
Flow
Physical Properties
Liquid
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A03579-1-APC 100 µg/Vial
Anti-CLASP2 Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
UAC15106-01 50 mg
3-Amino-6,7-dichloro-2,3-dihydro-1H-indol-2-one hydrochloride
Sign In for Pricing
View Details UAC15106-02 0.5 g
3-Amino-6,7-dichloro-2,3-dihydro-1H-indol-2-one hydrochloride
Sign In for Pricing
View Details 